Both M2a and M2d macrophages demonstrated a high phagocytosis response to Jurkat tumor cells, a known trait for anti-inflammatory macrophages, which was equally reduced upon HERA-CD40L, suggesting M2a and M2d macrophages in this context are comparable (Figure 4A) (42). The gene discussed is CD40LG; the disease is neoplasm.